Common use of Recommendations Clause in Contracts

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeutics, Inc.

Appears in 4 contracts

Sources: Subcontract Agreement, Research Agreement, Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into amending this Agreement with ONL Oncopia Therapeutics, Inc.LLC.

Appears in 3 contracts

Sources: Research Agreement, Research Agreement, Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Verge Therapeutics, Inc.

Appears in 2 contracts

Sources: Sponsored Activity Agreement, Subcontract Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Decibel Therapeutics, Inc.

Appears in 2 contracts

Sources: Research Agreement, Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL TherapeuticsPrehab Technologies, Inc.LLC dba Prenovo.

Appears in 1 contract

Sources: Subcontract Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL ▇▇▇▇▇▇ Therapeutics, Inc.

Appears in 1 contract

Sources: Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL between the University and OncoFusion Therapeutics, Inc.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL between the University and Diapin Therapeutics, Inc.LLC.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeuticsbetween the University and Morphomic Analysis Group, Inc.LLC.

Appears in 1 contract

Sources: Option Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Oncopia Therapeutics, Inc.LLC.

Appears in 1 contract

Sources: Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into amending this Agreement with ONL Therapeutics, Inc.PP2A Therapeutics Oy.

Appears in 1 contract

Sources: Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Millendo Therapeutics, Inc.

Appears in 1 contract

Sources: Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL IFM Therapeutics, Inc.

Appears in 1 contract

Sources: Research Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeutics, Inc.between the University and Elicit Software LLC.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL between the University and Niche Therapeutics, Inc.LLC.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeutics, between the University and OntMed Inc.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeutics, Inc.between the University and Mekanistic Therapeutics LLC.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeuticsbetween the University and Applied Morphomics, Inc.

Appears in 1 contract

Sources: License Agreement

Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with ONL Therapeutics, Inc.PP2A Therapeutics Oy.

Appears in 1 contract

Sources: Sponsored Activity Agreement